Literature DB >> 32404275

Role of oxidative stress in depression.

Shvetank Bhatt1, Anantha Naik Nagappa2, Chandragouda R Patil3.   

Abstract

Reactive oxygen species (ROS) have vital roles in cellular signaling and in defence against invasive microorganisms. Excessive ROS generation and exhaustion of antioxidative defences trigger proinflammatory signaling, damaging vital macromolecules and inducing cellular apoptosis. The failure of cells to maintain redox homeostasis and resultant generation of proinflammatory mediators leads to cell necrosis. The brain is more vulnerable to oxidative stress (OS) because of its higher oxygen consumption, higher lipid content, and weaker antioxidative defence. OS is a main cause of neurodegeneration and its involvement in the pathogenesis of major depressive disorder (MDD) is unequivocally established. OS and proinflammatory signaling have emerged as mainstays in the pathogenesis of MDD. Targeting these changes with suitable antioxidants could be an effective strategy to treat MDD.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32404275     DOI: 10.1016/j.drudis.2020.05.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  42 in total

1.  Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression.

Authors:  Haitham S Mohammed; Yasser A Khadrawy
Journal:  Lasers Med Sci       Date:  2021-09-06       Impact factor: 3.161

2.  Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression.

Authors:  Anthony J Hannan; Thibault Renoir; Volkan Uzungil; Harvey Tran; Connor Aitken; Carey Wilson; Carlos M Opazo; Shanshan Li; Jennyfer M Payet; Celeste H Mawal; Ashley I Bush; Matthew W Hale
Journal:  Neurotherapeutics       Date:  2022-07-21       Impact factor: 6.088

3.  Characterization of antidepressant activity of Saraca asoca flower (Roxb.) Wilde in mice subjected to acute restraint stress.

Authors:  Shashikumara Shashikumara; Krishna Purushotham; C L Darshan; Bhuvanesh Sukhlal Kalal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Antidepressant-like activity of oroxylin A in mice models of depression: A behavioral and neurobiological characterization.

Authors:  Zhong-Hua Wu; Hua Fan; Shang-Yan Gao; Yan-Fei Jin; Bo Jiang; Jian Shen
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

Review 5.  Targeting inflammation: a potential approach for the treatment of depression.

Authors:  Shvetank Bhatt; Thangaraj Devadoss; Niraj Kumar Jha; Moushumi Baidya; Gaurav Gupta; Dinesh Kumar Chellappan; Sachin Kumar Singh; Kamal Dua
Journal:  Metab Brain Dis       Date:  2022-10-14       Impact factor: 3.655

6.  The Antidepressant Effect of Deoiled Sunflower Seeds on Chronic Unpredictable Mild Stress in Mice Through Regulation of Microbiota-Gut-Brain Axis.

Authors:  Xiaomeng Lu; Ce Qi; Jie Zheng; Mei Sun; Long Jin; Jin Sun
Journal:  Front Nutr       Date:  2022-07-01

7.  Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders.

Authors:  Katarzyna Bliźniewska-Kowalska; Piotr Gałecki; Kuan-Pin Su; Angelos Halaris; Janusz Szemraj; Małgorzata Gałecka
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

Review 8.  Therapeutic Effect and Mechanisms of Essential Oils in Mood Disorders: Interaction between the Nervous and Respiratory Systems.

Authors:  Timothy K H Fung; Benson W M Lau; Shirley P C Ngai; Hector W H Tsang
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 9.  Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression-A Literature Review.

Authors:  Young Sup Woo; Hyun Kook Lim; Sheng-Min Wang; Won-Myong Bahk
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

Review 10.  Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.

Authors:  Bernardino Clavo; Gregorio Martínez-Sánchez; Francisco Rodríguez-Esparragón; Delvys Rodríguez-Abreu; Saray Galván; David Aguiar-Bujanda; Juan A Díaz-Garrido; Silvia Cañas; Laura B Torres-Mata; Himar Fabelo; Teresa Téllez; Norberto Santana-Rodríguez; Leandro Fernández-Pérez; Gustavo Marrero-Callico
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.